BE1002295A5 - Medicaments. - Google Patents

Medicaments. Download PDF

Info

Publication number
BE1002295A5
BE1002295A5 BE8900740A BE8900740A BE1002295A5 BE 1002295 A5 BE1002295 A5 BE 1002295A5 BE 8900740 A BE8900740 A BE 8900740A BE 8900740 A BE8900740 A BE 8900740A BE 1002295 A5 BE1002295 A5 BE 1002295A5
Authority
BE
Belgium
Prior art keywords
methyl
drugs
cylco
carbazol
piroxicam
Prior art date
Application number
BE8900740A
Other languages
English (en)
French (fr)
Inventor
Keith Thomas Bunce
Patrick Paul Anthony Humphrey
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Application granted granted Critical
Publication of BE1002295A5 publication Critical patent/BE1002295A5/fr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/60Salicylic acid; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
BE8900740A 1988-07-07 1989-07-06 Medicaments. BE1002295A5 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888816187A GB8816187D0 (en) 1988-07-07 1988-07-07 Medicaments

Publications (1)

Publication Number Publication Date
BE1002295A5 true BE1002295A5 (fr) 1990-11-20

Family

ID=10640032

Family Applications (1)

Application Number Title Priority Date Filing Date
BE8900740A BE1002295A5 (fr) 1988-07-07 1989-07-06 Medicaments.

Country Status (14)

Country Link
US (1) US4983621A (https=)
JP (1) JPH0276815A (https=)
AU (1) AU633496B2 (https=)
BE (1) BE1002295A5 (https=)
CA (1) CA1330306C (https=)
CH (1) CH679553A5 (https=)
DE (1) DE3922263A1 (https=)
DK (1) DK336489A (https=)
FR (1) FR2633831B1 (https=)
GB (2) GB8816187D0 (https=)
IT (1) IT1232155B (https=)
NL (1) NL8901727A (https=)
SE (1) SE8902458L (https=)
ZA (1) ZA895142B (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06508836A (ja) * 1991-06-26 1994-10-06 セプラコア,インコーポレーテッド 光学的に純粋なr(+)オンダンセトロンを使用する嘔吐、吐き気および他の障害の治療のための方法および組成物
GB9310756D0 (en) * 1993-05-25 1993-07-14 Glaxo Lab Sa Compositions
GB9710767D0 (en) * 1996-06-26 1997-07-23 On Ninh Analgesic and anti-inflamatory compositions comprising domperidone and methods of using same
GB9816899D0 (en) 1998-08-05 1998-09-30 Boots Co Plc Therapeutic agents
AU2002230935A1 (en) * 2000-10-30 2002-05-15 Teva Pharmaceutical Industries Ltd. Novel crystal and solvate forms of ondansetron hydrochloride and processes for their preparation
DK1499623T3 (da) * 2002-04-29 2007-10-08 Teva Gyogyszerg Ar Zartkoeruee Fremgangsmåde til fremstilling af 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-4H-carbazol-4-on
US20050131045A1 (en) * 2002-04-30 2005-06-16 Judith Aronhime Novel crystal forms of ondansetron, processes for their preparation, pharmaceutical, compositions containing the novel forms and methods for treating nausea using them
WO2004010955A2 (en) * 2002-07-31 2004-02-05 Sepracor Inc. Cyclooxygenase-2 inhibitors for appetite suppression
CA2673049C (en) * 2006-12-22 2016-02-23 Novadel Pharma Inc. Stable anti-nausea oral spray formulations and methods

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2105193A (en) * 1981-09-04 1983-03-23 Glaxo Group Ltd Pharmaceutical compositions containing non-steroidal anti-inflammatory agents
EP0272876B1 (en) * 1986-12-17 1993-10-13 Glaxo Group Limited Use of heterocyclic derivatives for the manufacture of medicaments

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB105193A (en) * 1916-08-29 1917-04-05 Thomas Joseph Mills Improvements in Rotary Printing Machines.
AU528098B2 (en) * 1978-11-16 1983-04-14 Beecham Group Plc Analgesic tablet
US4309408A (en) * 1978-11-16 1982-01-05 Beecham Group Limited Effervescent powders
EP0201165B1 (en) * 1985-03-14 1994-07-20 Beecham Group Plc Medicaments for the treatment of emesis
GB8516083D0 (en) * 1985-06-25 1985-07-31 Glaxo Group Ltd Heterocyclic compounds

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2105193A (en) * 1981-09-04 1983-03-23 Glaxo Group Ltd Pharmaceutical compositions containing non-steroidal anti-inflammatory agents
EP0272876B1 (en) * 1986-12-17 1993-10-13 Glaxo Group Limited Use of heterocyclic derivatives for the manufacture of medicaments

Also Published As

Publication number Publication date
ZA895142B (en) 1990-06-27
CA1330306C (en) 1994-06-21
JPH0276815A (ja) 1990-03-16
DK336489D0 (da) 1989-07-06
SE8902458L (sv) 1990-01-08
DK336489A (da) 1990-01-08
IT1232155B (it) 1992-01-25
CH679553A5 (https=) 1992-03-13
FR2633831A1 (fr) 1990-01-12
AU633496B2 (en) 1993-02-04
GB2220352A (en) 1990-01-10
GB2220352B (en) 1992-03-18
GB8816187D0 (en) 1988-08-10
NL8901727A (nl) 1990-02-01
US4983621A (en) 1991-01-08
GB8915499D0 (en) 1989-08-23
IT8948163A0 (it) 1989-07-06
SE8902458D0 (sv) 1989-07-06
DE3922263A1 (de) 1990-01-11
AU3790489A (en) 1990-01-11
FR2633831B1 (fr) 1993-11-19

Similar Documents

Publication Publication Date Title
BE1002249A4 (fr) Compositions pharmaceutiques.
IL119627A0 (en) Controlled-release pharmaceutical preparations
EP1233756A4 (en) SOLID CARRIER FOR IMPROVED ADMINISTRATION OF ACTIVE SUBSTANCES IN PHARMACEUTICAL COMPOSITIONS
EA200101026A1 (ru) Предварительно желатинированный крахмал в композиции с контролируемым высвобождением
ES2188782T3 (es) Formulaciones farmaceuticas que contienen darifenacina.
CA2326517A1 (en) New galenic preparations of meloxicam for oral administration
YU13695A (sh) Upotreba 2-fenil-3-aroilbenzotiofena i njihove farmaceutske formulacije
RU94032150A (ru) Лекарственное средство с замедленным высвобождением активно-действующего вещества
CA2105180A1 (en) Compositions containing sumatriptan
EP1365749A4 (en) PROCESS FOR PREPARING PHARMACEUTICAL COMPOSITIONS FOR USE WITH WEICHGELATINE FORMULATIONS
DK0724885T3 (da) Pernasal sammensætning og pernasalt præparat indeholdende dette
BE1002295A5 (fr) Medicaments.
RU95101385A (ru) Продукты, содержащие g-csf и tnf связующие протеина
KR880007073A (ko) 의 약 품
NO912416L (no) Terapeutisk aktiv benzimidazolforbindelse og fremgangsmaate for dens fremstilling.
KR880007074A (ko) 의약품
EP1027053A4 (en) METHOD FOR PREVENTING CYCLOSPORINES AND TACROLIMUS TO KIDNEY POISONING
BE1002255A5 (fr) Medicaments.
FR2660192B1 (fr) Formulation liposomiales pour l'administration topique ou vaginale de medicaments.
CA2135179A1 (en) Pharmaceutical Compositions of Alkylsulphonamides 5HT1 Agonists for Rectal Administration
BE1002256A3 (fr) Medicaments.
BE1002182A5 (fr) Compositions pharmaceutiques.
JPH0314812B2 (https=)
GEP20043377B (en) Pharmaceutical Complex
CA2259270A1 (en) Pharmaceutical preparation containing nimesulide for oral administration

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: GLAXO GROUP LTD

Effective date: 19950731